terfenadine has been researched along with Chronic Kidney Failure in 3 studies
Terfenadine: A selective histamine H1-receptor antagonist devoid of central nervous system depressant activity. The drug was used for ALLERGY but withdrawn due to causing LONG QT SYNDROME.
Excerpt | Relevance | Reference |
---|---|---|
"Fexofenadine clearance was not affected by time after dialysis (P = 0." | 1.56 | Chronic Inhibition of CYP3A is Temporarily Reduced by Each Hemodialysis Session in Patients With End-Stage Renal Disease. ( Åsberg, A; Christensen, H; Egeland, EJ; Robertsen, I; Witczak, BJ; Zaré, HK, 2020) |
"ESRD can affect the pharmacokinetic disposition of drugs subject to nonrenal clearance." | 1.35 | ESRD impairs nonrenal clearance of fexofenadine but not midazolam. ( Frye, RF; Himmelfarb, J; Le, P; Leblond, FA; Naud, J; Nolin, TD; Pichette, V; Sadr, H, 2009) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Egeland, EJ | 1 |
Witczak, BJ | 1 |
Zaré, HK | 1 |
Christensen, H | 1 |
Åsberg, A | 1 |
Robertsen, I | 1 |
Nolin, TD | 1 |
Frye, RF | 1 |
Le, P | 1 |
Sadr, H | 1 |
Naud, J | 1 |
Leblond, FA | 1 |
Pichette, V | 1 |
Himmelfarb, J | 1 |
Wong, J | 1 |
Phelps, R | 1 |
Levitt, J | 1 |
3 other studies available for terfenadine and Chronic Kidney Failure
Article | Year |
---|---|
Chronic Inhibition of CYP3A is Temporarily Reduced by Each Hemodialysis Session in Patients With End-Stage Renal Disease.
Topics: Aged; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cytochrome P-450 CYP3A; Drug Interact | 2020 |
ESRD impairs nonrenal clearance of fexofenadine but not midazolam.
Topics: Adult; Aged; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood Urea Nitrogen; | 2009 |
Treatment of acquired perforating dermatosis with cantharidin.
Topics: Aged; Anti-Allergic Agents; Cantharidin; Dermatologic Agents; Drug Therapy, Combination; Female; Hum | 2012 |